Category Archives: Nano Medicine

The term Nanotechnology is used when the developments occur at very miniscule 0.1 to 100 nm scale.Nanomedicineis an offshoot of Nanotechnology which basically involves development of medicines at a molecular stage. The medicines ae developed for treatment of life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, etc. These also have various other applications such as diagnosis, prevention and even regeneration of tissues.

The development of a nanomedicine is a tedious process and usually takes several years. These are based on technologies such as quantum dots, nanorobots, nanorods, nanoparticles, fullerenes, liposomes and more. The diagnosis field has more precise and reliable nanotechnology methods. These require minimum biological sample which facilitates considerable reduction in consumption of reagents and disposables. This technology is also widely used in drug delivery purpose due to nanoscale particles.

The Final Report will cover the impact analysis of COVID-19 on this industry.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10064965

Market Dynamics

A number of factors drive the market for Nanomedicine. The improvement in regulatory framework, the technology becoming more familiar, heavy funding and a positive mindset by the governments of various countries help its cause. Apart from these, a continuous increase in the aforementioned chronic diseases has been observed. Thus, there has been a phenomenal rise in the demand of nanomedicines. With new companies stated to enter the market, the supply-demand gap of nanomedicines will be bridged to a larger extent. There are debates on the toxicity of these medicines and the high cost associated to it but currently, the benefits outweigh the riskinvolved.

Market Segmentation

The basis of segmentation of this market is applications in medicines, targeted disease and geography. The application segment includes, drug delivery, drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging where drug delivery contributes higher than rest followed by in-vitro diagnostics. It is divided on the basis of diseases in the following segments: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Till 2012, the market was heavily dominated by oncology segment however currently, the cardiovascular nanomedicine market is the fastest growing.

Request For Sample Request:https://www.kennethresearch.com/sample-request-10064965

Regional/Geographic Analysis

The market was heavily dominated by the US but there has been a rise in the Asia Pacific region and is expected to grow faster owing to a rapid increase in geriatric population and rising awareness of healthcare. Even Europe is stated to grow faster than the US due to its extensive product pipeline portfolio and improving regulatory frameworks.

Key Players

Some of the major players in the market includeGE Healthcare, Abbott Laboratories,Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd.About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email : [emailprotected]

Phone: +1 313 462 0609

Read the rest here:
Healthcare Nanotechnology (Nanomedicine) Market is Anticipated to Register a Significant CAGR over a Forecast Period 2016-2022 - Germany English News

Global Biologic Therapeutics Market: Snapshot

The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics. Any pharmaceutical drug product manufactured from semi-synthesized and biological sources is included under this field. Owing to rapid advances experienced by this sector, a distinct biologic therapeutics market has formed. This market is mainly being driven by a rising demand for better healthcare treatments occurring all over the world.

Know the Growth Opportunities in Emerging Markets

The global biological therapeutics market mainly comprises of derivatives extracted from whole blood and other blood components, organs and tissue transplants, stem cell therapy, human breast milk, fecal microbiota, human reproductive cells, and antibodies. Several biological materials could are also extracted from other animals.

The global biological therapeutics market not only deals with extracted biologic materials from the market, but also involves providing treatments based on the use of these materials. Most biologic therapeutic substance include individual components such as thrombolytic agents, interferons, monoclonal antibodies, additional products, interleukin-based products, haematopoietic growth factors, hormones, and therapeutic enzymes. Materials used for producing biopharmaceuticals might also be derived from recombinant E. coli or yeast cultures, mammalian cell cultures, plant cell cultures, and mosses.

The global biologic therapeutics market is boosted through the presence of cancer, diabetes, and another coronary heart diseases. A growing geriatric population also has been responsible for making the market gain extensive revenue in the form of quality treatment processes. However, the market might be restrained due to high cost of extraction of the biologic materials. Nevertheless, extensive research and development carried out by many businesses in this market might offset the restraints substantially.

Global Biologic Therapeutics Market: Overview

The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues. Biological products are used to prevent diseases, diagnose diseases, or treat or cure medical conditions.

Global Biologic Therapeutics Market: Key Trends and Opportunities

First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.

Increasing prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and a growing geriatric population are some other factors contributing to the biologic therapeutics market. In addition, mounting clinical trials and innovative research and development practices to develop novel drugs is boosting the growth of biologic therapeutics market.

On the flip side, manufacturing difficulties due to complexities of drug molecules is challenging the growth of biologic therapeutics market. Nevertheless, increasing research and development in the pharmaceutical sector and rising applications of biologics is anticipated to provide new opportunities to this market.

Global Biologic Therapeutics Market: Market Potential

The Genetic Technology module for TechVision Opportunity Engine provides the most recent R&D advancements and developments while looking into opportunities for profit in the exploding genetic technology field via joint ventures, acquisitions, and technology transfer. The entire range of genetic technology applications covered in the module includes latest developments in omics technologies, which include genetic, cellular, and alternative therapies; genetically modified plants and animals, and sequencing technologies.

The health and wellness cluster of genetic technology techvision opportunity engine looks into developments across several areas, which include genetic engineering, drug discovery and development, regenerative medicine, cosmetic procedures, nanomedicine, drug delivery, smart healthcare, pain and disease management, and personalized medicine.

Order this Report TOC for Detailed Statistics

Global Biologic Therapeutics Market: Geographical Outlook

As per the reports analysis, the worldwide biologic therapeutics market could see a classification into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America, among them, could secure a leading position due to a robust research infrastructure and presence of expert researchers and scientists for biotechnology research. Europe is a key market for biologic therapeutics due to high level of biotechnology research and pioneering research in the field of biotechnology. Asia Pacific is likely to emerge as a significant market for biologic therapeutics with increasing advancement in biotechnology research.

Global Biologic Therapeutics Market: Competitive Landscape

The worldwide biologic therapeutics market is predicted to witness the prominence of several key players, namely Pfizer Inc., Novartis Global, Smith Medical, Concord Biotech, H. Lundbeck A/S, AstraZeneca, Merck & Co. Inc., GlaxoSmithKline plc, Aurobindo Pharma Ltd., and Retractable Technologies Inc. Market players could resort to common business strategies, viz. product innovation, cutting-edge developments, and acquisitions to push up growth in the market.

Read more here:
Biologic Therapeutics Market Dynamics, Segments, Size and Demand, 2017 2025 - Cole of Duty

Ming-Chen Sun,1,* Xiao-Ling Xu,1,* Xue-Fang Lou,2 Yong-Zhong Du1

1Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Peoples Republic of China; 2School of Medicine, Zhejiang University City College, Hangzhou 310015, Peoples Republic of China

*These authors contributed equally to this work

Correspondence: Yong-Zhong DuInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yu-Hang-Tang Road, Hangzhou 310058, Peoples Republic of ChinaTel +86-571-88208435Fax +86-571-88208439Email duyongzhong@zju.edu.cnXue-Fang LouSchool of Medicine, Zhejiang University City College, 51 Hu-Zhou Street, Hangzhou 310015, Peoples Republic of ChinaTel +86-571-88013011Fax +86-571-88018442Email louxf@zucc.edu.cn

Abstract: Vitiligo is a depigmentation disease that seriously affects the physical health, mental health and quality of life of a patient. Therapeutic aim at control immunoreaction by relieving oxidative stress. Unfortunately, the cuticle barrier function and lack of specific accumulation lead to unsatisfactory therapeutic outcomes and side effects. The introduction and innovation of nanotechnology offers inspiration and clues for the development of new strategies to treat vitiligo. However, not many studies have been done to interrogate how nanotechnology can be used for vitiligo treatment. In this review, we summarize and analyze recent studies involving nano-drug delivery systems for the treatment of vitiligo, with a special emphasis on liposomes, niosomes, nanohydrogel and nanoparticles. These studies made significant progress by either increasing drug loading efficiency or enhancing penetration. Based on these studies, there are three proposed principles for topical nano-drug delivery systems treatment of vitiligo including the promotion of transdermal penetration, enhancement of drug retention and facilitation of melanin regeneration. The presentation of these ideas may provide inspirations for the future development of topical drug delivery systems that will conquer vitiligo.

Keywords: vitiligo, nano-drug delivery system, transdermal penetration, liposomes, skin

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Go here to see the original:
Recent Progress and Future Directions: The Nano-Drug Delivery System f | IJN - Dove Medical Press

Technology makes processes easier, faster, safer, and more efficient. Shouldnt it, therefore, also reduce costs?

This isnt always the case. Thats because researching and developing new technology can cost millions of dollars; add to that the cost of materials and production. By the time that technology is launched, billions may have been spent developing it.

New technology has brought immense benefits to the following four industries, but it hasnt necessarily lowered costs for consumers.

Medical technology is so innovative that doctors can now insert tiny robotics into the body to repair internal wounds or remove objects. This is a branch of medicine called nanomedicine. Nanomedicine uses nanosized (even smaller than microsized) carriers to transport drugs to specific cells or tumors in the body. This form of technology opens up a new way to treat cancer, for instance. Rather than subject the entire body to chemotherapy, nanotechnology can deliver chemotherapy drugs directly to the tumor.

These types of treatments, however, dont come cheap. In fact, healthcare costs in the United States continue to rise. In 2018, the U.S spent $3.6 trillion on healthcare, which works out to an average of $11,000 per person. This is projected to increase to $18,000 per person by 2028.

One of the main drivers of escalating healthcare costs is medical technology. According to a report by The Hastings Center, healthcare economists found that 40 percent to 50 percent of annual healthcare cost increases were linked to new medical technologies.

Sustainable energy has a positive impact on the environment. Solar- and wind-powered energy mean less reliance on harmful fossil fuels for energy production. Electric cars eliminate toxic fuel emissions.

But solar panels can be costly to install, and electric cars are often more expensive to buy than traditional cars. Electric vehicles can range in pricing from $31,915 for a Nissan Leaf to $70,875 for the Jaguar I-Pace.

The good news is these products pay for themselves over time with the savings on your electric and gas bills. In addition, buying an electric car or implementing energy-saving technology in your home can make you eligible for a rebate. States like California offer rebates of up to $500 when installing solar products and up to $7,000 when buying an electric vehicle.

Many of the aviation safety systems that are standard on planes today were born from past mistakes. When an airplane crashes, a thorough investigation is conducted. The lessons learned from a catastrophic disaster often lead to improved safety technology.

The aviation industry has made giant strides in technology to make flying safer, lower the cost of fuel, and find ways to reduce airplane emissions. Engineers are looking at ways to manufacture lighter engines and using 3D printing to design and produce lighter aircraft parts. Every part that becomes lighter, even brackets and hinges, helps decrease the planes overall weight and boost fuel efficiency.

In their quest to reduce their carbon footprint, aircraft manufacturers are following the example of the automotive industry and testing electric engines for airplanes. Theyre also testing biofuels, such as sugarcane and cooking oil. According to NASA, a 50/50 blend of jet fuel and biofuel can cut soot emissions by 50 percent. While this is great for the environment, flying a plane with biofuels costs more than traditional jet fuel.

Despite new technology and lower fuel costs, travelers are unlikely to see a drop in the cost of flights. And with the COVID-19 pandemic grounding planes across the globe, many airlines are likely to try to recoup losses by charging higher fares when travel resumes.

Car safety technology, like collision avoidance systems, blind-spot monitoring, automated braking, lane keep assist, and rear-view backup cameras have become standard on most new cars.

Despite the fact that the National Highway Traffic Safety Administration and the Insurance Institute for Highway Safety agree that safety tech in cars is effective in reducing car crashes, insurance companies havent lowered their rates on cars that feature them. The only car safety technologies that lower insurance rates are electronic stability control and telematics.

If car tech helps prevent accidents, why arent insurance rates lower? Insurance companies cite the following reasons:

Technology improves our lives in many ways, but it doesnt always lower costs. In some cases, it may even increase the cost of goods or services. The tradeoff is in what we gain from new technologies: more efficiency, better safety, time-saving convenience, and less damage to the environment.

Visit link:
The Benefits of Tech Even Those That Don't Cut Costs - The Tech Report

Transportation restrictions and stringent government policies are causing a downturn in the growth scale of the Nanomedicine market amidst the COVID-19 (Coronavirus) lockdown period. Hence, analysts at Market Research Reports Search Engine (MRRSE) have collated a research study that provides an in-depth outlook on Coronavirus and how the novel virus can leave long-term effects in trade practices post lockdown period in the Nanomedicine market.

Why Choose MRRSE?

Request Sample Report @https://www.mrrse.com/sample/3117?source=atm

The report on the global Nanomedicine market published by MRRSE provides a clear understanding of the flight of the Nanomedicine market over the forecast period (20XX-20XX). The study introspects the various factors that are tipped to influence the growth of the Nanomedicine market in the upcoming years. The current trends, growth opportunities, restraints, and major challenges faced by market players in the Nanomedicine market are analyzed in the report.

The study reveals that the global Nanomedicine market is projected to reach a market value of ~US$XX by the end of 20XX and grow at a CAGR of ~XX% during the assessment period. Further, a qualitative and quantitative analysis of the Nanomedicine market based on data collected from various credible sources in the market value chain is included in the report along with relevant tables, graphs, and figures.

Key Takeaways of the Report:

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/3117?source=atm

Nanomedicine Market Segmentation

The presented study throws light on the current and future prospects of the Nanomedicine market in various geographies such as:

The report highlights the product adoption pattern of various products in the Nanomedicine market and provides intricate insights such as the consumption volume, supply-demand ratio, and pricing models of the following products:

market dynamics section of this report analyzes the impact of drivers and restraints on the global nanomedicine market. The impact of these drivers and restraints on the global nanomedicine market provides a view on the market growth during the course of the forecast period. Increasing research activities to improve the drug efficacy coupled with increasing government support are considered to be some of the major driving factors in this report. Moreover, few significant opportunities for the existing and new market players are detailed in this report.

Porters five forces analysis provides insights on the intensity of competition which can aid in decision making for investments in the global nanomedicine market. The market attractiveness section of this report provides a graphical representation for attractiveness of the nanomedicine market in four major regions North America, Europe, Asia-Pacific and Rest of the World, based on the market size, growth rate and industrial environment in respective regions, in 2012.

The global nanomedicine market is segmented on the basis of application and geography and the market size for each of these segments, in terms of USD billion, is provided in this report for the period 2011 2019. Market forecast for this applications and geographies is provided for the period 2013 2019, considering 2012 as the base year.

Based on the type of applications, the global nanomedicine market is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other applications. Other applications include dental, hematology, orthopedic, kidney diseases, ophthalmology, and other therapeutic and diagnostic applications of nanomedicines. Nanoparticle based medications are available globally, which are aimed at providing higher bioavilability and hence improving the efficacy of drug. There have been increasing research activities in the nanomedicine filed for neurology, cardiovascular and oncology applications to overcome the barriers in efficient drug delivery to the target site. Moreover, the global nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and Rest of the World. This section describes the nanomedicine support activities and products in respective regions, thus determining the market dynamics in these regions.

The report also provides a few recommendations for the exisitng as well as new players to increase their market share in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.

More here:
Potential impact of coronavirus outbreak on Nanomedicine Market Potential Growth, Share and Demand-Analysis of Key Players- Research Forecasts to 2024...

Endo International

The scope of the Report:

The report analyzes the key opportunities, CAGR, and Y-o-Y growth rates to allow readers to understand all the qualitative and quantitative aspects of the Healthcare Nanotechnology (Nanomedicine) market. A competition analysis is imperative in the Healthcare Nanotechnology (Nanomedicine) market and the competition landscape serves this objective. A wide company overview, financials, recent developments, and long and short-term strategies adopted are par for the course. Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in the sales of Healthcare Nanotechnology (Nanomedicine) across the world has been calculated through primary and secondary research. The Healthcare Nanotechnology (Nanomedicine) Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

By Regions:

* North America (The US, Canada, and Mexico)

* Europe (Germany, France, the UK, and Rest of the World)

* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

* Latin America (Brazil and Rest of Latin America.)

* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=NYH&utm_medium=888

Highlights of the Healthcare Nanotechnology (Nanomedicine) market study:

Speculations for sales:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Healthcare Nanotechnology (Nanomedicine) market. Additionally, it includes a share of every segment of the Healthcare Nanotechnology (Nanomedicine) market, giving methodical information about types and applications of the market.

Key point summary of the Healthcare Nanotechnology (Nanomedicine) market report:

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It presents an in-depth analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by creating a pin-point analysis of market segments and by having complete insights of the Healthcare Nanotechnology (Nanomedicine) market.

This report helps users in comprehending the key product segments and their future.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Healthcare Nanotechnology (Nanomedicine) market

Chapter 2: Evaluating the leading manufacturers of the global Healthcare Nanotechnology (Nanomedicine) market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales

Chapter 4: Presenting global Healthcare Nanotechnology (Nanomedicine) market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Finally, the report global Healthcare Nanotechnology (Nanomedicine) market describes Healthcare Nanotechnology (Nanomedicine) industry expansion game plan, the Healthcare Nanotechnology (Nanomedicine) industry knowledge supply, appendix, analysis findings and the conclusion. It includes a through explanation of the cutting-edging technologies and investments being made to upgrade the existing ones.

Report customization:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Get Complete Report @ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=NYH&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Healthcare Nanotechnology (Nanomedicine) Market Size, Healthcare Nanotechnology (Nanomedicine) Market Trends, Healthcare Nanotechnology (Nanomedicine) Market Growth, Healthcare Nanotechnology (Nanomedicine) Market Forecast, Healthcare Nanotechnology (Nanomedicine) Market Analysis sarkari result, sarkari exam, sarkari naukri

Our Trending Reports

Offshore AUV and ROV Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Oil & Gas Analytics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the article here:
Healthcare Nanotechnology (Nanomedicine) Market 2020 | Growth Drivers, Challenges, Trends, Market Dynamics and Forecast to 2026 - Cole of Duty